OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
Francesca Saluzzo, Luca Riberi, Barbara Messore, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1243-1243
Open Access | Times Cited: 31
Francesca Saluzzo, Luca Riberi, Barbara Messore, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1243-1243
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Standards for the care of people with cystic fibrosis; establishing and maintaining health
Kevin W Southern, C. Addy, Scott C. Bell, et al.
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 1, pp. 12-28
Open Access | Times Cited: 29
Kevin W Southern, C. Addy, Scott C. Bell, et al.
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 1, pp. 12-28
Open Access | Times Cited: 29
Genetic Concordance of Staphylococcus aureus From Oropharyngeal and Sputum Cultures in People With Cystic Fibrosis
Christian F. Zirbes, Andries Feder, Anthony J. Pamatmat, et al.
Pediatric Pulmonology (2025) Vol. 60, Iss. 1
Open Access
Christian F. Zirbes, Andries Feder, Anthony J. Pamatmat, et al.
Pediatric Pulmonology (2025) Vol. 60, Iss. 1
Open Access
Short-term modification of breathprint by Elexacaftor/Tezacaftor/Ivacaftor in a paediatric cohort
Emmanuelle Bardin, N. Hunzinger, Elodie Lamy, et al.
Journal of Cystic Fibrosis (2025)
Open Access
Emmanuelle Bardin, N. Hunzinger, Elodie Lamy, et al.
Journal of Cystic Fibrosis (2025)
Open Access
Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort Study
Vered Wiesel, Micha Aviram, Meir Mei‐Zahav, et al.
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 1, pp. 41-49
Closed Access | Times Cited: 19
Vered Wiesel, Micha Aviram, Meir Mei‐Zahav, et al.
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 1, pp. 41-49
Closed Access | Times Cited: 19
Eradication of Mycobacterium abscessus infection in cystic fibrosis with initiation of Elexacaftor/Tezacaftor/Ivacaftor
Caoimhe McParland, Matthew Nunn, Theodore K. Marras, et al.
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 1, pp. 38-40
Closed Access | Times Cited: 12
Caoimhe McParland, Matthew Nunn, Theodore K. Marras, et al.
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 1, pp. 38-40
Closed Access | Times Cited: 12
Clinical and radiological improvement of cavitary Mycobacteroides abscessus disease in cystic fibrosis following initiation of elexacaftor/tezacaftor/ivacaftor
Roderick Gavey, J D Nolan, Vanessa Moore, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 5, pp. 1024-1026
Open Access | Times Cited: 3
Roderick Gavey, J D Nolan, Vanessa Moore, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 5, pp. 1024-1026
Open Access | Times Cited: 3
Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations
Christina S. Thornton, Lindsay J. Caverly, Linda M. Kalikin, et al.
Annals of the American Thoracic Society (2023) Vol. 21, Iss. 4, pp. 595-603
Closed Access | Times Cited: 8
Christina S. Thornton, Lindsay J. Caverly, Linda M. Kalikin, et al.
Annals of the American Thoracic Society (2023) Vol. 21, Iss. 4, pp. 595-603
Closed Access | Times Cited: 8
Durable transgene expression and efficient re-administration after rAAV2.5T-mediated fCFTRΔR gene delivery to adult ferret lungs
Yinghua Tang, Mehrnoosh Ebadi, Junying Lei, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 2, pp. 101244-101244
Open Access | Times Cited: 2
Yinghua Tang, Mehrnoosh Ebadi, Junying Lei, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 2, pp. 101244-101244
Open Access | Times Cited: 2
A systematic review on the use of bacteriophage in treating Staphylococcus aureus and Pseudomonas aeruginosa infections in cystic fibrosis
Jagdev Singh, Eugene Yeoh, Dominic A. Fitzgerald, et al.
Paediatric Respiratory Reviews (2023) Vol. 48, pp. 3-9
Closed Access | Times Cited: 7
Jagdev Singh, Eugene Yeoh, Dominic A. Fitzgerald, et al.
Paediatric Respiratory Reviews (2023) Vol. 48, pp. 3-9
Closed Access | Times Cited: 7
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections
Tegan M. Hibbert, Marvin Whiteley, Stephen A. Renshaw, et al.
Critical Reviews in Microbiology (2023), pp. 1-16
Open Access | Times Cited: 7
Tegan M. Hibbert, Marvin Whiteley, Stephen A. Renshaw, et al.
Critical Reviews in Microbiology (2023), pp. 1-16
Open Access | Times Cited: 7
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy
Pietro Ripani, Matteo Mucci, Stefano Pantano, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Pietro Ripani, Matteo Mucci, Stefano Pantano, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Cystic Fibrosis-Related Nontuberculous Mycobacterial Pulmonary Disease
Timothy Baird, Scott C. Bell
Clinics in Chest Medicine (2023) Vol. 44, Iss. 4, pp. 847-860
Closed Access | Times Cited: 6
Timothy Baird, Scott C. Bell
Clinics in Chest Medicine (2023) Vol. 44, Iss. 4, pp. 847-860
Closed Access | Times Cited: 6
Tetramerization is essential for the enzymatic function of the Pseudomonas aeruginosa virulence factor UDP-glucose pyrophosphorylase
Larissa Dirr, Sven Cleeves, Isabel Ramón Roth, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 1
Larissa Dirr, Sven Cleeves, Isabel Ramón Roth, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 1
Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor–tezacaftor–ivacaftor combination: a 1-year observational study
Chiara Blardone, Simone Gambazza, Alessandra Mariani, et al.
Therapeutic Advances in Respiratory Disease (2024) Vol. 18
Open Access | Times Cited: 1
Chiara Blardone, Simone Gambazza, Alessandra Mariani, et al.
Therapeutic Advances in Respiratory Disease (2024) Vol. 18
Open Access | Times Cited: 1
Toward better cures for Mycobacterium abscessus lung disease
Véronique Dartois, Thomas Dick
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 1
Véronique Dartois, Thomas Dick
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 1
Phage therapy to treat cystic fibrosis Burkholderia cepacia complex lung infections: perspectives and challenges
Jack S. Canning, Daniel R. Laucirica, Kak‐Ming Ling, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Jack S. Canning, Daniel R. Laucirica, Kak‐Ming Ling, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Longitudinal bacterial prevalence in cystic fibrosis airways: Fact and artifact
Donald R. VanDevanter, John J. LiPuma, Michael W. Konstan
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 1, pp. 58-64
Closed Access | Times Cited: 4
Donald R. VanDevanter, John J. LiPuma, Michael W. Konstan
Journal of Cystic Fibrosis (2023) Vol. 23, Iss. 1, pp. 58-64
Closed Access | Times Cited: 4
Bile effects on the Pseudomonas aeruginosa pathogenesis in cystic fibrosis patients with gastroesophageal reflux
Mobina Bayat, Javid Sadri Nahand, Nader Farsad-Akhatr, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22111-e22111
Open Access | Times Cited: 4
Mobina Bayat, Javid Sadri Nahand, Nader Farsad-Akhatr, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22111-e22111
Open Access | Times Cited: 4
Associations of the <i>VDR</i> gene with clinical manifestations and complications of cystic fibrosis
Е. В. Лошкова, E. Kondratyeva, E. Zhekaite, et al.
PULMONOLOGIYA (2023) Vol. 33, Iss. 4, pp. 443-453
Open Access | Times Cited: 3
Е. В. Лошкова, E. Kondratyeva, E. Zhekaite, et al.
PULMONOLOGIYA (2023) Vol. 33, Iss. 4, pp. 443-453
Open Access | Times Cited: 3
Cystic fibrosis: comorbidity with other serious diseases
G. N. Yankinа, Elena Ivanovna Kondratieva, Е. В. Лошкова, et al.
Experimental and Clinical Gastroenterology (2023), Iss. 3, pp. 98-111
Open Access | Times Cited: 2
G. N. Yankinа, Elena Ivanovna Kondratieva, Е. В. Лошкова, et al.
Experimental and Clinical Gastroenterology (2023), Iss. 3, pp. 98-111
Open Access | Times Cited: 2
Cystic Fibrosis Transmembrane Regulator Modulator Therapy Perspective: Findings in Clinical Outcomes in a Series of Pediatric Patients
O.C. Patran, Laura Dracea
Bulletin of the Transilvania University of Brasov Series VI Medical Sciences (2024), pp. 35-40
Closed Access
O.C. Patran, Laura Dracea
Bulletin of the Transilvania University of Brasov Series VI Medical Sciences (2024), pp. 35-40
Closed Access
Advances in Research on Aging in Female Infertility and Pathologic Pregnancy
Bin Liu, Gendie E. Lash, Fengxiang Wei, et al.
Frontiers research topics (2024)
Open Access
Bin Liu, Gendie E. Lash, Fengxiang Wei, et al.
Frontiers research topics (2024)
Open Access
Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: an open-label proof-of-concept study
Emmanuelle Bardin, Hélène Salvator, Camille Roquencourt, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Emmanuelle Bardin, Hélène Salvator, Camille Roquencourt, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Fatty acid abnormalities in cystic fibrosis –the missing link for a cure?
Sławomira Drzymała-Czyż, Jarosław Walkowiak, Carla Colombo, et al.
iScience (2024) Vol. 27, Iss. 11, pp. 111153-111153
Closed Access
Sławomira Drzymała-Czyż, Jarosław Walkowiak, Carla Colombo, et al.
iScience (2024) Vol. 27, Iss. 11, pp. 111153-111153
Closed Access
Current knowledge on Inquilinus limosus, a scarcely researched human pathogen
Oluwafemi M. Akinnurun, Thomas Riedel, Stephanie Müller, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access
Oluwafemi M. Akinnurun, Thomas Riedel, Stephanie Müller, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access
